Ultragenyx Pharmaceutical Inc.

BNP Paribas Asset Management Holding S.A. RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,899,661

Value ($000)

43,692

Weight

0.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	43,692	0.1%	1,899,661	12/31/2025
2025 Q3	11/7/2025	46,482	0.1%	1,545,279	9/30/2025
2025 Q2	8/6/2025	52,800	0.1%	1,452,130	6/30/2025